BlineSlide
Deep Breathe, Inc. · Decision date Oct 23, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for BlineSlide, a 510(k) submitted by Deep Breathe, Inc. of London, Canada, under 510(k) number K261679. The device falls under the classification name Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer, regulation number 892.2060, product code POK, in the Radiology specialty and review panel. The application was received 05/21/2026 and decided 10/23/2026. SESE denotes clearance to market, not premarket approval of a new device system.
The record identifies the submission as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. The applicant contact and correspondent are listed as Robert Arntfield. The public record does not include the summary statement, so the specific software functions, intended use wording, and any performance data supporting equivalence remain unknown from this source.
No clinical, efficacy, or labeling conclusions are drawn here; those details would require the underlying FDA decision documents, which were not available in the provided material.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Oct 23, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261679
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Deep Breathe, Inc.
- Product code
- POK
- Decision code
- SESE
- Decision date
- Oct 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer.
- Applicant
- Deep Breathe, Inc.
- Product code
- POK
- FDA device class
- 2
FDA decision timeline
K261679 received
Application receipt date recorded by FDA.
K261679 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Deep Breathe, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- London
Sources and methodology
- Original FDA record: K261679
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records